Amneal Pharmaceuticals (AMRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist

8.490
+0.020+0.24%

Close Nov 1 16:00 ET

8.490
0.0000.00%

Post 16:20 ET

2.63BMarket Cap-10746P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Amneal Gets FDA Nod for NDA of Its Neuromuscular Disorder Treatment
Seeking AlphaOct 21 08:45 ET
Amneal Pharmaceuticals Gets FDA Approval for Pyridostigmine Bromide
WSJOct 21 08:26 ET
Amneal Receives U.S. FDA Approval Of New Drug Application For Pyridostigmine Bromide Extended-Release Tablets
BenzingaOct 21 08:08 ET
Express News | Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
ReutersOct 21 08:00 ET
Amneal Pharmaceuticals' (NASDAQ:AMRX) Investors Will Be Pleased With Their Stellar 193% Return Over the Last Five Years
Simply Wall StOct 15 10:13 ET
Amneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Yahoo FinanceOct 9 18:10 ET

Comments

Trytosaveabit

Oct 21 07:01

News

$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

Trytosaveabit

Oct 1 05:06

Update

$Amneal Pharmaceuticals (AMRX.US)$ Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...

Trytosaveabit

Sep 5 15:07

Ne2s hehehe NEWS

$Amneal Pharmaceuticals (AMRX.US)$ Reuters
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration

Trytosaveabit

Aug 20 07:01

News

$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just1
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials! expects launch in Q4

Stock Region

Aug 8 11:29

Global Pharmaceuticals Company Receives FDA Approval For Parkinson's Disease Treatment

FDA Approves CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Parkinson's Disease: A New Horizon in Treatment.
Amneal Pharmaceuticals, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease (PD). This novel formulation promises to address some of the longstanding cha...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

AMRX Amneal Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target